PLAY PODCASTS
Market View: Bristol Myers $4.1 billion acquisition, Microstrategy, Intel, Adani Green, Apple, Vibecession ending, Chinese gaming firms share buybacks, Goldman’s 2023 lesson on China, Astrazeneca buys Cancer Drug Developer for $1.2 billion

Market View: Bristol Myers $4.1 billion acquisition, Microstrategy, Intel, Adani Green, Apple, Vibecession ending, Chinese gaming firms share buybacks, Goldman’s 2023 lesson on China, Astrazeneca buys Cancer Drug Developer for $1.2 billion

Your Money with Michelle Martin · MONEY FM 89.3

December 27, 202320m 47s

Audio is streamed directly from the publisher (traffic.omny.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Is the ‘vibecession’ really coming to an end? What’s the latest on Pharmaceutical acquisitions? And why are Chinese gaming firms unveiling share buybacks even after the latest regulatory move unnerved investors? Michelle Martin discusses with Ryan Huang.

See omnystudio.com/listener for privacy information.